Structure-guided inhibitor design targeting CntL provides the first chemical validation of the staphylopine metallophore system in bacterial metal acquisition.

MLA

Luo, Zhiteng, et al. “Structure-Guided Inhibitor Design Targeting CntL Provides the First Chemical Validation of the Staphylopine Metallophore System in Bacterial Metal Acquisition.” European Journal of Medicinal Chemistry, vol. 280, Oct. 2024, p. 116991. EBSCOhost, https://doi.org/10.1016/j.ejmech.2024.116991.

APA

Luo, Z., Su, J., Luo, S., Ju, Y., Chen, B., Gu, Q., & Zhou, H. (2024). Structure-guided inhibitor design targeting CntL provides the first chemical validation of the staphylopine metallophore system in bacterial metal acquisition. European Journal of Medicinal Chemistry, 280, 116991. https://doi.org/10.1016/j.ejmech.2024.116991

Chicago

Luo, Zhiteng, Jingtian Su, Siting Luo, Yingchen Ju, Bingyi Chen, Qiong Gu, and Huihao Zhou. 2024. “Structure-Guided Inhibitor Design Targeting CntL Provides the First Chemical Validation of the Staphylopine Metallophore System in Bacterial Metal Acquisition.” European Journal of Medicinal Chemistry 280 (October): 116991. doi:10.1016/j.ejmech.2024.116991.